Table 2.

Cases of recurrence of G2 EEC and their characteristics.

Stage	LVSI	Symptoms	Site	Treatment	Disease-Free Survival (Months)	Survival After Recurrence (Months)
IA	Absent	Vaginal bleeding	Vaginal vault + pelvic LN	BSC	29	14
IA	Absent	Persistent cough	Lungs	HT	42	33
IA	Absent	1st—asymptomatic (found on examination) 2nd—shortness of breath	1st—inguinal LN 2nd—ediastinal LN	1st SE 2nd BSC	57	29
IB	Present	Abdominal pain	Lungs + LN (supraclavicular, para-aortic, pelvic)	BSC	8	3
IB	Present	Diabetic complications + diarrhoea	Paracardiac LN + peritoneum + omentum + sigmoid	HT	11	10
IB	Absent	Persistent cough	lungs + mediastinal LN + adrenal	BSC	21	3
IB	Absent	Persistent discharge	Vaginal vault	Chemotherapy	3	24
IB	Present	Vaginal bleeding	Vaginal vault + pelvic LN (recurrence as G3 ECC)	Chemotherapy	23	43
IB	Absent	Fatigue and reduced appetite	Peritoneum—malignant ascites + LN (retrocaval, paracardiac)	BSC	63	8
IB	Present	1st—vaginal bleeding 2nd—shortness of breath	1st—vaginal vault 2nd—lungs	1st SE 2nd CT	27	58
IB	Present	Asymptomatic (incidental finding on CT scan for other reason)	Peritoneal nodularity and ascites (small volume disease) + umbilical nodule	RT + HT	31	78
IB	Present	Vaginal bleeding	Vaginal vault + pelvic tumour	SE + HT	27	107
IIIA	Present	Diarrhoea	Pelvic + paraaortic LN	RT	18	42
IIIA	Absent	Pelvic pain	Lungs + bones	RT + HT	55	24
IIIB	Present	Asymptomatic (found on examination)	Vaginal vault + pelvic LN	HT	9	5
IIIB	Present	Vaginal bleeding	1st—vaginal vault 2nd—pelvic LN + bones	1st SE 2nd BSC	37	14

LN = lymph nodes; RT = radiotherapy; CT = chemotherapy; HT = hormonotherapy; BSC = best supportive care; SE = surgical excision.